These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8958338)

  • 1. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of the month: germline mosaicism in carriers of Duchenne muscular dystrophy.
    Prior TW; Papp AC; Snyder PJ; Mendell JR
    Muscle Nerve; 1992 Aug; 15(8):960-3. PubMed ID: 1353862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
    Hutton EM; Thompson MW
    Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne muscular dystrophy and idiopathic hyperCKemia segregating in a family.
    Frydman M; Straussberg R; Shomrat R; Goebel H; Legum C; Shiloh Y
    Am J Med Genet; 1995 Sep; 58(3):209-12. PubMed ID: 8533818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers.
    Wenger SL; Steele MW; Hoffman EP; Barmada MA; Wessel HB
    Am J Med Genet; 1992 Aug; 43(6):1012-5. PubMed ID: 1415326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic counseling issues in the use of DNA analysis for Duchenne/Becker muscular dystrophy.
    Cortada JM; Milsark I; Richards CS
    Birth Defects Orig Artic Ser; 1990; 26(3):231-7. PubMed ID: 2092850
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
    Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
    Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of DNA probes to carrier detection and prenatal diagnosis of Duchenne (and Becker) muscular dystrophy.
    Mulley JC; Gedeon AK; Haan EA; Sheffield LJ; White SJ; Bates LJ; Robertson EF; Sutherland GR
    Aust Paediatr J; 1988; 24 Suppl 1():92-7. PubMed ID: 3202740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy.
    Williams WR; Thompson MW; Morton NE
    Am J Med Genet; 1983 Feb; 14(2):315-33. PubMed ID: 6837627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin.
    Morandi L; Mora M; Gussoni E; Tedeschi S; Cornelio F
    Ann Neurol; 1990 Nov; 28(5):674-9. PubMed ID: 1979724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic counselling for Duchenne muscular dystrophy].
    Ousawa M; Saito K; Ikeya K; Fukuyama Y
    No To Shinkei; 1991 May; 43(5):429-41. PubMed ID: 1910929
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive muscular dystrophy].
    Sugita H
    No To Shinkei; 1986 Feb; 38(2):111-20. PubMed ID: 3516182
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential pitfalls in using DNA probes to counsel Duchenne and Becker muscular dystrophy families.
    Shi YJ; Fischbeck KH; Ritter A
    Chin Med J (Engl); 1992 Jun; 105(6):469-75. PubMed ID: 1451547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.